Energy News / Shareholders Foundation, Inc.

NASDAQ: BDSI Investor Alert: Lawsuit Filed Against BioDelivery Sciences International, Inc.

Via: ReleaseWire

Updated 12:15 PM CDT, Wed, October 09,2019

A lawsuit was on behalf of investors in BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares and NASDAQ: BDSI stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 10/09/2019 -- An investor in shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) filed a lawsuit against BioDelivery Sciences International and its board of directors..

Investors who purchased shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) and currently hold any of those NASDAQ: BDSI shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that certain directors of BioDelivery Sciences International, Inc. enacted charter amendments without proper approval from shareholders of BioDelivery Sciences International, Inc. that ended staggered director terms and changed stockholder voting rules.

The plaintiff claims that certain provisions were put in place despite failure to obtain a required majority vote from shareholders of BioDelivery Sciences International, Inc. in 2018.

Raleigh, NC based BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioDelivery Sciences International, Inc. reported that its annual Total Revenue declined from $61.18 million in 2017 to $55.64 million in 2018 and that its Net Income of $5.28 million in 2017 turned into a Net Loss of $33.86 million in 2018.

Shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) closed on August 8, 2019 at $4.03 per share.

Those who purchased shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-bdsi-investor-alert-lawsuit-filed-against-biodelivery-sciences-international-inc-1262313.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com